Prolonged effects of adenoviral vector priming on T-cell cytokine production in heterologous adenoviral vector/mRNA COVID-19 vaccination regimens
Abstract mRNA and adenoviral vector vaccine platforms were used for the primary series of COVID-19 vaccines in many countries. However, the distinct immunogenic properties on these platforms remain less understood. We traced neutralizing antibodies, memory B cells, and T cells longitudinally in coho...
Saved in:
| Main Authors: | Masanori Isogawa, Taishi Onodera, Akira Ainai, Ryutaro Kotaki, Takayuki Kanno, Shinji Saito, Minoru Tobiume, Kenzo Tokunaga, Megumi Hara, Yoshio Hirota, Tadaki Suzuki, Yoshimasa Takahashi, Tomomi Tsuru |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-00054-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Developing the next-generation of adenoviral vector vaccines
by: Alexander T. Sampson, et al.
Published: (2025-12-01) -
Adenoviral Vectors for Gene Therapy of Hereditary Diseases
by: Anna Muravyeva, et al.
Published: (2024-12-01) -
Bovine Adenoviral Vector-Based Platform for Vaccine Development
by: Ekramy E. Sayedahmed, et al.
Published: (2025-05-01) -
Immunogenicity of various variants of Ebola and Marburg virus glycoprotein genes in recombinant adenoviral vectors
by: T. A. Ozharovskaia, et al.
Published: (2024-10-01) -
DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)
by: L. V. Cherenova, et al.
Published: (2017-08-01)